Logos

Graham Walmsley is a Managing Partner at Logos Capital, where he works on the firm's private investments and structured public investing. He was previously a Principal and Portfolio Manager of the Vantage crossover fund at Versant Ventures, where he served as a board director and helped build biotechnology companies including BlueRock Therapeutics and Akero Therapeutics, and led business development for Jecure Therapeutics. He has authored more than 60 peer-reviewed publications and holds an MD and PhD from Stanford University School of Medicine.

Benjamin Chan is a Finance Manager at Logos Capital, handling finance and accounting functions across the firm. He previously oversaw financial activities and fund operations at Alta Park Capital, and earlier served as Vice President of Investment Operations at ICONIQ Capital, managing fund accounting, taxes, and administration. He holds a B.S. in Finance from California State University, Sacramento.

Brandon Adams is an Investment Analyst at Logos Capital. He previously worked as a Research Analyst at Point72 Asset Management, covering biotechnology and large cap pharma on a market neutral healthcare team, and earlier held analyst roles at a biotech-focused hedge fund and in Piper Sandler's Biopharma investment banking group. He earned a B.S. in Biochemistry from Saint Mary's College of California.

Cynthia Goldsmith is the Chief Financial Officer at Logos Capital, overseeing the firm's finance and accounting functions across its funds. She previously served as CFO at Asymmetry Capital Management and held roles at Forward Management and Kensington Investment Group, including managing hedge fund administration and accounting. She is a Certified Public Accountant and holds a B.S. in Accounting from the University of California, Berkeley.

Derek Gould is General Counsel and Chief Compliance Officer at Logos Capital, handling the firm's legal and regulatory matters. He previously held the same roles at Figment Capital and served as Chief Compliance Officer and Counsel at SRS Investment Management, with earlier positions at Folger Hill Asset Management and Apollo Global Management. He earned a BS in Engineering from the University of Michigan and a JD from the Benjamin N. Cardozo School of Law.

Udit Dalal is Vice President of Operations at Logos Capital, where he oversees the firm's internal fund operations. He previously worked at Goldman Sachs Prime Brokerage as a Vice President managing client relationships and providing operational support to California hedge funds, and held earlier roles at Morgan Stanley Prime Brokerage in New York. He holds an MBA from the LeBow School of Business at Drexel University and an undergraduate degree from the University of Mumbai.

Arsani William is Managing Partner and Chief Investment Officer at Logos, where he oversees portfolio construction, risk management, and strategy across public and private markets. Before founding Logos, he worked as an investment professional at Farallon Capital Management, contributing to its biopharma portfolio and investment framework. Trained as a physician, he earned his MD at Harvard Medical School, an MBA at Stanford Graduate School of Business, and a BS in Biology at Stanford University.